[1] Grossman SD, Rosenberg LJ, Wrathall JR. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp Neurol. 2001;168(2):273-282.
[2] Herbertson A, Aubin JE. Cell sorting enriches osteogenic populations in rat bone marrow stromal cell cultures. Bone. 1997;21(6):491-500.
[3] Nishimura R, Okuda K. Hypoxia is important for establishing vascularization during corpus luteum formation in cattle. J Reprod Dev. 2010;56(1):110-116.
[4] Fiorenzo P, Mongiardi MP, Dimitri D, et al. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Int J Oncol. 2010; 36(4):785-791.
[5] DE Lima PO1, Jorge CC, Oliveira DT, et al. Hypoxic condition and prognosis in oral squamous cell carcinoma. Anticancer Res. 2014;34(2):605-612.
[6] Liang YC, Wu HG, Xue HJ, et al. Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells. J Huazhong Univ Sci Technolog Med Sci. 2013;33(6):845-851.
[7] Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 1987; 20(3):263-272.
[8] Zohar R, Sodek J, McCulloch CA. Characterization of stromal progenitor cells enriched by flow cytometry. Blood. 1997;90(9): 3471-3481.
[9] Tropel P, Noël D, Platet N, et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res. 2004;295(2):395-406.
[10] Wan C, Gilbert SR, Wang Y, et al. Activation of the hypoxia-inducible factor-1-alpha pathway accelerates. Proc Nat Acad Sci. 2008;105(2):686-691.
[11] Giaccia A , Siim BG , Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov. 2003;2(10):803-811.
[12] Bai L, Yang JC, Ok JH, et al. Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration. Int J Cancer. 2012;130(11):2693-2702.
[13] Konstantina A, Lazaris AC, Ioannidis E, et al. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi. Melanoma Res. 2011;21(5):389-394.
[14] Coma S, Shimizu A, Klagsbrun M. Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2. Cell Adh Migr. 2011;5(3): 266-275.
[15] Bruick RK , McKnight SL . A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001; 294 (5545):1337-1340.
[16] Evans CE, Humphries J, Mattock K, et al. Hypoxia and upregulation of hypoxia- inducible factor 1{alpha} stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol. 2010;30(12):2443-2451.
[17] Lando D , Peet DJ , Whelan DA , et al. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 2002;295(5556):858-861.
[18] Liu X, Du J, Xi Q. HIF-1α ODD polypeptides increased the expression of HIF1 and VEGF in hypoxic rat cortical neuron. Neurol Sci. 2011;32(6):1029-1033.
[19] Toussaint M, Fievez L, Desmet CJ, et al. Increased hypoxia-inducible factor 1α expression in lung cells of horses with recurrent airway obstruction. BMC Vet Res. 2012;8:64.
[20] Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4(5):267-274.
[21] Muñoz-Elías G, Woodbury D, Black IB. Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions. Stem Cells. 2003;21(4):437-448.
[22] Dougherty KD, Dreyfus CF, Black IB. Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis. 2000;7(6 Pt B):574-585.
[23] Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995;92(11):4857-4861.
[24] Emans PJ , Spaapen F , Surtel DA , et al. A novel in vivo model to study endochondral bone formation;HIF-1α activation and BMP expression. Bone. 2007;40(2):409-418.
[25] Huang SM, Chen TS, Chiu CM, et al. GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interaction. Endocr Relat Cancer. 2013;21(1):73-84.
[26] Zimmermann SM, Würgler-Hauri CC, Wanner GA, et al. Echinomycin in the prevention of heterotopic ossification - an experimental antibiotic agent shows promising results in a murine model. Injury. 2013;44(4):570-575.
[27] Rodrigues B, Jorge L, Mostarda CT, et al. Aerobic exercise training delays cardiac dysfunction and improves autonomic control of circulation in diabetic rats undergoing myocardial infarction. J Card Fail. 2012;18(9):734-744.
[28] Medina Villaamil V, Aparicio Gallego G, Santamarina Caínzos I, et al. Searching for Hif1-α interacting proteins in renal cell carcinoma. Clin Transl Oncol. 2012;14(9):698-708.
[29] Huang C, Hales BF. Effects of exposure to a DNA damaging agent on the hypoxia inducible factors in organogenesis stage mouse limbs. PLoS One. 2012,7(12):e51937.
[30] Weijts BG, Bakker WJ, Cornelissen PW, et al. E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1. EMBO J. 2012;31(19): 3871-3884.
[31] Lin J, Qin X, Zhu Z, et al. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization ofHIF1α and HIF1β. IUBMB Life. 2012;64(11):921-930.
[32] Lim W, Cho J, Kwon HY, et al. Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta. FEBS Lett. 2009;583(8):1314-1318.
[33] Wu WJ, Zhang XK, Zheng XF, et al. SHH-dependent knockout of HIF-1 alpha accelerates the degenerative process in mouse intervertebral disc. Int J Immunopathol Pharmacol. 2013;26(3):601-609.
[34] Wang X, Wang G, Kunte M, et al. Modulation of angiogenesis by genetic manipulation of ATF4 in a mouse modulation of angiogenesis by genetic manipulation. Invest Ophthalmol Vis Sci. 2013;54(9):5995-6002.
[35] Artini PG, Simi G, Ruggiero M, et al. DHEA supplementation improves follicular microenviroment in poor responder patients. Gynecol Endocrinol. 2012;28(9):669-673.
[36] Larrieu-Lahargue F, Welm AL, Bouchecareilh M, et al. Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis. PLoS One. 2012;7(6):e39540.
[37] Tao X, Zhao N, Jin H, et al. FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3. Endocr Relat Cancer. 2013;20(3):415-429.
[38] Shan B, Schaaf C, Schmidt A, et al. Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas. J Endocrinol. 2012;214(3):389-398.
[39] Zhang Z, Wang G, Li C, et al. Construction and characterization of a recombinant human adenovirus vector expressing bone morphogenetic protein 2. Exp Ther Med. 2013;6(2):329-334.
[40] Romano G , Michell P , Pacilio C, et al. Latest developments in gene transfer technology:achievements,perspectives,and controversies over therapeutic applicat- ions. Stem Cells. 2000; 18(1):19-39.
[41] Seregin SS, Amalfitano A . Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opin Biol Ther. 2009; 9(12):1521-1531.
[42] Douglas JT . Adenoviral vectors for gene therapy. Mol Biotechnol. 2007;36(1):71-80.
[43] Elson DA , Thurston G , Huang LE , et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 2001;15(19):2520-2532. |